Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1952 2
1953 3
1954 3
1956 3
1957 1
1958 1
1962 1
1965 1
1967 4
1968 1
1969 1
1970 2
1971 5
1972 4
1973 6
1974 4
1975 2
1976 8
1977 8
1978 12
1979 8
1980 4
1981 9
1982 3
1983 5
1984 14
1985 15
1986 16
1987 18
1988 11
1989 17
1990 14
1991 9
1992 12
1993 9
1994 9
1995 10
1996 10
1997 3
1998 3
1999 4
2000 5
2001 9
2002 5
2003 17
2004 13
2005 12
2006 11
2007 4
2008 12
2009 6
2010 9
2011 9
2012 6
2013 9
2014 10
2015 16
2016 11
2017 12
2018 10
2019 7
2020 6
2021 9
2022 10
2023 5
2024 2
2025 6
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

489 results

Results by year

Filters applied: . Clear all
Page 1
Patient and Tumor Factors Influencing Diagnostic Trajectories in Gastrointestinal Stromal Tumor Patients and Their Impact on Health-Related Quality of Life: A Dutch Multicenter Study.
van Amerongen T, Holthuis EI, van de Wal D, Hollander DD, Desar IME, Gelderblom H, Oosten AW, Reyners AKL, Steeghs N, Groen JS, Van der Graaf WTA, Husson O. van Amerongen T, et al. Among authors: hollander dd. Ann Surg Oncol. 2026 Aug;33(8):7331-7342. doi: 10.1245/s10434-026-19763-2. Epub 2026 May 14. Ann Surg Oncol. 2026. PMID: 42135544 Free PMC article.
Health-related quality of life in patients with advanced soft tissue sarcoma receiving first-line palliative chemotherapy (HOLISTIC): longitudinal results from a prospective, observational cohort study.
Roets E, Younger E, Jones RL, Hollander DD, Azarang L, Desar IME, Young RJ, Oosten AW, de Haan JJ, Gelderblom H, Steeghs N, Husson O, van der Graaf WTA. Roets E, et al. Among authors: hollander dd. EClinicalMedicine. 2025 Oct 16;89:103561. doi: 10.1016/j.eclinm.2025.103561. eCollection 2025 Nov. EClinicalMedicine. 2025. PMID: 41146924 Free PMC article.
Efficacy and safety of DaxibotulinumtoxinA for injection in adults with cervical dystonia: Pooled global analysis of ASPEN-1 and ASPEN-1-CN randomized trials.
Ellenbogen A, Xingyue H, Lingjing J, Banach M, Patel AT, Gross TM, Kazerooni R, Gallagher CJ, Xiaojing F, Wang H, Lei G, Xinhua W, Hollander DA. Ellenbogen A, et al. Among authors: hollander da. Parkinsonism Relat Disord. 2025 Nov;140:108015. doi: 10.1016/j.parkreldis.2025.108015. Epub 2025 Sep 2. Parkinsonism Relat Disord. 2025. PMID: 40961718 Free article. Clinical Trial.
Long-Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN-Open-Label Study.
McAllister P, Patel AT, Banach M, Ellenbogen A, Slawek J, Paus S, Jinnah HA, Evidente V, Gross TM, Kazerooni R, Gallagher CJ, Hollander DA. McAllister P, et al. Among authors: hollander da. Mov Disord Clin Pract. 2025 Nov;12(11):1764-1773. doi: 10.1002/mdc3.70104. Epub 2025 May 29. Mov Disord Clin Pract. 2025. PMID: 40439027 Free PMC article. Clinical Trial.
Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. Toxins 2024, 16, 442".
Dashtipour K, Lee HS, Ellenbogen A, Kazerooni R, Gross TM, Hollander DA, Gallagher CJ. Dashtipour K, et al. Among authors: hollander da. Toxins (Basel). 2025 Apr 11;17(4):191. doi: 10.3390/toxins17040191. Toxins (Basel). 2025. PMID: 40278689 Free PMC article.
Double burden: financial toxicity in patients with advanced soft tissue sarcoma at the start of first-line palliative chemotherapy: baseline data from the HOLISTIC study.
Roets E, Younger E, Jones RL, Hollander DD, Desar IME, Young RJ, Oosten AW, de Haan JJ, Gelderblom H, Steeghs N, van der Graaf WTA, Husson O. Roets E, et al. Among authors: hollander dd. Support Care Cancer. 2025 Feb 27;33(3):228. doi: 10.1007/s00520-025-09248-5. Support Care Cancer. 2025. PMID: 40011242 Free PMC article.
489 results